GEN | Industry Updates: Exelixis’ Cabozantinib Demonstrates Broad Clinical Activity in Multiple Tumor Types - http://www.genengnews.com/industr...
Jun 5, 2011
from
Exelixis? Cabozantinib Demonstrates Broad Clinical Activity in Multiple Tumor Types - http://is.gd/cf9DEQ
– ACOR Cancer News (cancer_news) http://twitter.com/cancer_...
- Sally Church